Synovus Financial Corp lessened its stake in Oracle Co. (NYSE:ORCL - Free Report) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 164,930 shares of the enterprise software provider's stock after selling 9,715 shares during the period. Synovus Financial Corp's holdings in Oracle were worth $27,486,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Principal Financial Group Inc. raised its holdings in shares of Oracle by 5.3% during the 3rd quarter. Principal Financial Group Inc. now owns 2,416,362 shares of the enterprise software provider's stock valued at $411,748,000 after buying an additional 121,874 shares in the last quarter. McClarren Financial Advisors Inc. lifted its holdings in shares of Oracle by 201.7% in the 4th quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider's stock worth $266,000 after acquiring an additional 1,069 shares during the last quarter. RMR Wealth Builders boosted its stake in shares of Oracle by 383.4% in the 4th quarter. RMR Wealth Builders now owns 7,155 shares of the enterprise software provider's stock valued at $1,192,000 after purchasing an additional 5,675 shares in the last quarter. Foundations Investment Advisors LLC grew its holdings in shares of Oracle by 24.8% during the 4th quarter. Foundations Investment Advisors LLC now owns 164,593 shares of the enterprise software provider's stock valued at $27,428,000 after purchasing an additional 32,718 shares during the last quarter. Finally, Crews Bank & Trust purchased a new position in Oracle in the 4th quarter worth $1,800,000. Institutional investors own 42.44% of the company's stock.
Insider Transactions at Oracle
In related news, Director Naomi O. Seligman sold 2,000 shares of the company's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the transaction, the director now directly owns 34,630 shares of the company's stock, valued at $5,049,400.30. This represents a 5.46 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Leon E. Panetta sold 5,000 shares of the stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total value of $648,850.00. Following the completion of the transaction, the director now directly owns 58,090 shares in the company, valued at $7,538,339.30. This represents a 7.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 2,453,328 shares of company stock worth $454,439,851. 42.20% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the company. KeyCorp reaffirmed an "overweight" rating and issued a $200.00 price target on shares of Oracle in a research note on Tuesday, March 11th. Mizuho dropped their price target on Oracle from $210.00 to $180.00 and set an "outperform" rating on the stock in a research report on Tuesday. Stifel Nicolaus decreased their target price on shares of Oracle from $175.00 to $150.00 and set a "hold" rating for the company in a research note on Tuesday, March 11th. Guggenheim reiterated a "buy" rating and issued a $220.00 price target on shares of Oracle in a research note on Thursday, April 3rd. Finally, DA Davidson decreased their price target on Oracle from $150.00 to $140.00 and set a "neutral" rating for the company in a research note on Monday. Thirteen analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Oracle presently has a consensus rating of "Moderate Buy" and an average price target of $177.12.
Check Out Our Latest Analysis on ORCL
Oracle Trading Down 0.6 %
Shares of NYSE ORCL traded down $0.81 during trading hours on Tuesday, hitting $133.83. 8,619,117 shares of the company traded hands, compared to its average volume of 9,290,326. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. The company's 50 day moving average price is $153.73 and its 200 day moving average price is $167.15. The stock has a market capitalization of $374.33 billion, a price-to-earnings ratio of 32.72, a price-to-earnings-growth ratio of 3.46 and a beta of 1.22. Oracle Co. has a 12 month low of $112.78 and a 12 month high of $198.31.
Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.49 by ($0.02). The firm had revenue of $14.13 billion during the quarter, compared to analysts' expectations of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.41 EPS. On average, equities research analysts anticipate that Oracle Co. will post 5 earnings per share for the current fiscal year.
Oracle Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend is Thursday, April 10th. This is an increase from Oracle's previous quarterly dividend of $0.40. Oracle's dividend payout ratio is 46.95%.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report